AI Drug Development Problem

AI in Drug Discovery: A Patent Predicament
Recent breakthrough: AI discovered new antibiotics after a 40-year drought in the field.
But here's the catch:

Clinical testing costs ~$1 billion+
Without patent protection, who will invest?

The dilemma:
→ If AI-discovered drugs can't be patented, we risk blocking crucial innovation
→ This contradicts the very purpose of the IP system, which aims to encourage innovation
Consider this:

AI is revolutionizing drug discovery
But our current patent system isn't designed for AI inventors

The stakes are high:

Potential life-saving treatments
Billions in R&D investments
The future of pharmaceutical innovation

Good news: Both the copyright and patent offices are reconsidering their approach.
Key questions we need to address:

How do we attribute inventorship for AI discoveries?
What changes are needed in patent law to accommodate AI innovation?
How can we balance protecting IP rights with promoting public health?

As AI reshapes the landscape of innovation, our legal frameworks must evolve.
What's your take on AI-generated patents?
How can we ensure our IP system keeps pace with technological advancements?
💬 Share your thoughts below.